Sartorius (OTCMKTS:SARTF) Shares Shorted: Short Interest Up 282.2% in October

Sartorius (OTCMKTS:SARTF) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 1,827 shares, a growth of 282.2% from the September 30th total of 478 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Sartorius Stock Performance

Shares of SARTF stock opened at $243.86 on Friday. The company has a market cap of $8.35 billion, a price-to-earnings ratio of 113.42 and a beta of 0.98. Sartorius has a 52 week low of $181.58 and a 52 week high of $243.86. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. The firm has a 50 day moving average of $230.79 and a 200-day moving average of $222.00.

About Sartorius

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.

The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.